Cognitive Impairment in Pediatric Onset Multiple Sclerosis
NCT ID: NCT03190902
Last Updated: 2017-06-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
36 participants
INTERVENTIONAL
2015-09-15
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Rehabilitation and Brain Activity of Attention-Control Impairment in TBI
NCT04199130
The Effects of Attention Retraining in MS
NCT01492023
Effect of Working Memory Training on ADHD Brain Function
NCT02151396
Attention Intervention Management
NCT01779427
Use of Neurofeedback to Enhance Attention After Brain Injury
NCT03324178
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
ADHD is one of the most common neurodevelopmental disorders characterized by pervasive patterns of inattention and/or impulsivity/hyperactivity and a range of cognitive dysfunctions that often persist into adulthood.
POMS represent 5-10% of total MS population. Cognitive dysfunction is one of the most remarkable features of MS, and, particularly in POMS, the percentage of patients with at least a mild cognitive deficit ranges from 30 to 80%. The most affected cognitive domains in POMS are complex attention, information processing speed, executive functions, verbal and visual memory, reasoning and problem solving.
The functional consequences of cognitive impairment can be particularly striking in children and adolescents since they occur during formative years in the academic career and may affect their social activities. Cognitive training, during the developmental age, when brain plasticity is at the highest expression, can induce a strengthening of the key brain networks implicated in POMS and ADHD. To date the efficacy of specific cognitive rehabilitation interventions has never been evaluated by a randomized controlled trials (RCTS) in POMS. Conversely, in the last years, several RCTs assessed the efficacy of cognitive training as a potential non-drug alternative treatment for ADHD disorder.Most of the cognitive trainings focused on the working memory or attention dysfunctions. Preliminary evidence suggests that cognitive remediation might be at least partially effective in the ADHD treatment. It is argued that cognitive training can reduce ADHD symptoms and improve functioning by targeting neuropsychological deficits thought to mediate ADHD pathophysiology.
During the study project "Cognitive impairment in Pediatric Onset Multiple Sclerosis: research of biomarkers predictive of cognitive impairment progression", which is aimed to assess clinical, radiological and biological markers in pediatric subjects, POMS and ADHD patients will be recruited to assess the efficacy of a home-based computerized program for retraining attention dysfunction.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
specific computer training (ST) - POMS
Attention Processing Training program (APT)
nonspecific computer training (n-ST) - POMS
nonspecific computer training (n-ST)
specific computer training (ST) - ADHD
Attention Processing Training program (APT)
nonspecific computer training (n-ST) - ADHD
nonspecific computer training (n-ST)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Attention Processing Training program (APT)
nonspecific computer training (n-ST)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age \<18 years;
* Expanded Disability Status Scale (EDSS) score ≤5.5;
* impairment on at least 2/4 attention tests defined as scores \<1.5 standard deviation (SD) of normative values;
* ADHD patients with the subtype inattention;
* ADHD diagnosis performed according the DSM-5 criteria and the NIMH Collaborative Multisite Multimodal Treatment Study of Children With Attention- Deficit/Hyperactivity Disorder (MTA) - Swanson, Nolan, and Pelham IV Rating Scale (MTA-SNAP-IV), Conner's Parent Rating Scale Revised (CPRS-R), Conner's Teacher Rating Scale Revised (CTRS-R), Child Behavior Checklist (CBCL), Kiddie Schedule for Affective Disorder and Schizophrenia (K-SADS);
* age \<18 years;
* impairment on at least 2/4 attention tests defined as scores \<1.5 standard deviation (SD) of normative values;
Exclusion Criteria
* severe visual loss (unable to read Times New Roman font 16 with the best correction);
* major psychiatric illness;
* alcohol or substance abuse;
* education \<5 years;
* previous cognitive rehabilitation training;
* ongoing relapse or steroid treatment during the 30 days preceding enrollment;
* ADHD subtype hyperactivity;
* previously exposure or treatment with any psychotropic drug.
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pietro Iaffaldano
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pietro Iaffaldano
MD
References
Explore related publications, articles, or registry entries linked to this study.
Simone M, Viterbo RG, Margari L, Iaffaldano P. Computer-assisted rehabilitation of attention in pediatric multiple sclerosis and ADHD patients: a pilot trial. BMC Neurol. 2018 Jun 8;18(1):82. doi: 10.1186/s12883-018-1087-3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CR001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.